Clinical Trial On UTI

"An Open Non Randomized Single Arm Clinical Trial To Evaluate The Efficacy Of Nannari Manapagu In Neer Surukku (Urinary Tract Infections)"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037743

Enrollment

Registered

2021-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Nannari Manapagu: 15 grams Bid with water for 30 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptoms of burning micturition, dysuria, increased frequency, retention of urine, fever with rigor. Patients whose urine culture is positive for Escherchia coli, Stphylococcus aeureus, Klebseilla pneumonia, Pseudomonas aeuroginosa.

Exclusion criteria

Exclusion criteria: Chronic kidney disease as defined by estimated glomerular filtration rate(GFR) by the original Schwartz formula Genitourinary abnormalities including: previous genitourinary surgery(other than circumcision), neurogenic bladder conditions, known obstructive uropathy, known high-grade vesicoureteral reflux(Grades IV-V), Urolithiasis. Immunocompromised host. Pregnancy. Patients with Diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
Negative urine culture. Urine analysis report normal.Timepoint: 30 days	—

Secondary

Measure	Time frame
Patients will be free from dysyuria, abdominal pain, burning micturition. Quality of the life will be improved.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactSivaranjani

Siddha Clinical Research Unit,Playamkottai.

sivagsmcmd@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026